Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina

/ 2024, CIESP, Evaluación de Tecnologías Sanitarias, Publicaciones Científicas / Por

C. Rojas-Roque,C. Silvestrini,F. Argento,D. Sugg,F. Augustovski,J. Coelli and N. Espinola. Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics – Open. 2024:10.1007/s41669-024-00495-6.

Ir a la publicación